Genesis Pharma S.A.

	Message from the Board of Directors
	Vision and Mission
	Board of Directors
	History
	Regional Presence
	Sales and Marketing
	Business Development
	Medical Department
	Regulatory Affairs Department
	Logistics

History

1997

GENESIS Pharma was founded as the first Greek pharmaceutical company to focus on the sales and marketing of specialized biopharmaceutical products.
Exclusive Agreement signed with Biogen for Avonex^® in Greece.
Exclusive Agreement signed with Vifor for Venofer^® in Greece.

1998

1999

2000

2001

2002

Distribution Agreements with Amgen for the distribution of Granulokine^®and Neulasta^®in Greece and Kineret^®in Greece and Cyprus.
Distribution Agreements with Shire for Xagrid^®in Greece and Cyprus.
"Avonex Distributor of the Year" Award, by Biogen for Avonex^® .

2003

"Corporate Social Responsibility" Award (Annual National Advertising & PR Congress) for an awareness-raising programme for Multiple Sclerosis patients in Greece.
"Excellence and Outstanding Sales Performance" Award, by Amgen, for the sales of Amgen products in Greece and Cyprus.
Voted 8th Company in the 2003 Best Workplaces^® Competition in Greece.
"Avonex Distributor of the Year" Award, by Biogen Idec for Avonex^® .

2004

GENESIS Pharma establishes a representative office in Bulgaria
Awarded "Certificate of Recognition" at The Economist Corporate Social Responsibility Forum, for outstanding achievement in corporate social responsibility and sustained business performance.
Voted 7th in the 2004 Best Workplaces^® Competition in Greece.
"Avonex Distributor of the Year" Award, by Biogen for Avonex^®

2005

Voted 5th in the 2005 Best Workplaces^® Competition in Greece
Voted among the top 100 companies to work for in the 2005 Best Workplaces^® Competition in Europe.
"Avonex Distributor of the Year" Award, by Biogen for Avonex^®

2006

Distribution Agreement s with Alfacell Corporation for ONCONASE^®
Distribution Agreement with IDM Pharma for Mepact
Distribution Agreement with Celgene Corporation for Revlimid.
Distribution Agreements with Amgen for Mimpara and Kepivance.
Distribution Agreement with Shire for Fosrenol.
Mr C.Evripides, GENESIS Pharma CEO, was voted as the "Dynamic Entrepreneur of the Year 2006" in the international competition «Entrepreneur Of The Year".
GENESIS Pharma has been listed No. 316 among the fastest growing European companies included in the 2006 Europe's 500 Listing, the annual ranking of high growth, job-creating companies published by Europe's 500 - Entrepreneurs for Growth.
"Avonex Distributor of the Year" Award, by Biogen for Avonex^®
Voted 3rd in the 2006 Best Workplaces^® Competition in Greece
Voted among the top 100 companies to work for in the 2006
Best Workplaces^® Competition in Europe

2007

Renewal of distribution agreement with Biogen Idec for Avonex
Distribution agreement with Biogen Idec for Tysabri.
Distribution Agreement with PharmaMar for Yondelis
Voted 4th in the 2007 Best Workplaces^® Competition in Greece and awarded (special commendation) as the sole company in Greece to have been voted onto this list for six consecutive years.
Voted, for three consecutive years, among the top 100 companies to work for, in the 2007 Best Workplaces^® Competition in Europe.
"Avonex Distributor of the Year" Award, by Biogen for Avonex^® .
"Best Tysabri Launch Worldwide" for our launch of Tysabri in Greece, by Biogen
Distribution agreement with CellSeed Inc. for Cell-Sheet
Renewal of distribution agreements for the products (Aranesp, Neulasta,
Granulokine, Mimpara, Kineret, Kepivance) of Amgen

2008

Voted 4th in the 2008 Best Workplaces Competition in Greece
Voted, for four consecutive years, among the top 100 companies to work for, in the 2008 Best Workplaces^® Competition in Europe.
"Avonex Distributor of the Year" Award, by Biogen for Avonex^® .
Renewal of distribution agreement with Celgene for Revlimid
Distribution agreements with Celgene for Thalidomide, Refludan and Vidaza
Distribution agreements with Biovitrum for Kineret and Kepivance after the acquisition of Kepivance and licensing of Kineret by Biovitrum from Amgen.

2009